189 related articles for article (PubMed ID: 10390324)
1. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
Andersen M; Overgaard K; Meden P; Boysen G; Choi SC
Stroke; 1999 Jul; 30(7):1464-71. PubMed ID: 10390324
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia.
Schäbitz WR; Li F; Irie K; Sandage BW; Locke KW; Fisher M
Stroke; 1999 Feb; 30(2):427-31; discussion 431-2. PubMed ID: 9933283
[TBL] [Abstract][Full Text] [Related]
4. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia.
Sobrado M; López MG; Carceller F; García AG; Roda JM
Neuroscience; 2003; 118(1):107-13. PubMed ID: 12676142
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
Sereghy T; Overgaard K; Boysen G
Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
[TBL] [Abstract][Full Text] [Related]
6. Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia.
Ramos-Cabrer P; Agulla J; Argibay B; Pérez-Mato M; Castillo J
Int J Pharm; 2011 Feb; 405(1-2):228-33. PubMed ID: 21168478
[TBL] [Abstract][Full Text] [Related]
7. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
Overgaard K; Sereghy T; Pedersen H; Boysen G
Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
[TBL] [Abstract][Full Text] [Related]
8. The effects of prolonged treatment with citicoline in temporary experimental focal ischemia.
Schäbitz WR; Weber J; Takano K; Sandage BW; Locke KW; Fisher M
J Neurol Sci; 1996 Jun; 138(1-2):21-5. PubMed ID: 8791234
[TBL] [Abstract][Full Text] [Related]
9. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
Overgaard K; Sereghy T; Pedersen H; Boysen G
Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
Vanderschueren S; Van Vlaenderen I; Collen D
Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
[TBL] [Abstract][Full Text] [Related]
12. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
13. The effects of early insulin treatment combined with thrombolysis in rat embolic stroke.
Meden P; Andersen M; Overgaard K; Rasmussen RS; Boysen G
Neurol Res; 2002 Jun; 24(4):399-404. PubMed ID: 12069290
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase.
Shuaib A; Yang Y; Li Q
Exp Neurol; 2000 Feb; 161(2):733-9. PubMed ID: 10686092
[TBL] [Abstract][Full Text] [Related]
15. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
Stroke; 1992 Aug; 23(8):1167-73; discussion 1174. PubMed ID: 1636193
[TBL] [Abstract][Full Text] [Related]
16. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.
Secades JJ; Alvarez-Sabín J; Castillo J; Díez-Tejedor E; Martínez-Vila E; Ríos J; Oudovenko N
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1984-96. PubMed ID: 27234918
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.
Onal MZ; Li F; Tatlisumak T; Locke KW; Sandage BW; Fisher M
Stroke; 1997 May; 28(5):1060-5. PubMed ID: 9158650
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis and neuroprotection in cerebral ischemia.
Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
[TBL] [Abstract][Full Text] [Related]
20. CDP-choline at high doses is as effective as i.v. thrombolysis in experimental animal stroke.
Gutiérrez-Fernández M; Leciñana MA; Rodríguez-Frutos B; Ramos-Cejudo J; Roda JM; Díez-Tejedor E
Neurol Res; 2012 Sep; 34(7):649-56. PubMed ID: 22732142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
